17 September, 2024Arzeda secures $38M in oversubscribed funding round to advance protein design commercialization efforts
16 September, 2024AAVantgarde announces first patient dosed with AAVB-081 in FIH Phase 1/2 LUCE-1 study for retinitis pigmentosa related to USH1B
12 September, 2024F2G announces $100 million financing to advance late-stage development and commercialization of novel antifungal drug candidate Olorofim in the US
12 September, 2024Novameat raises €17.4M oversubscribed Series A round led by Sofinnova Partners and Forbion